esorubicin has been researched along with Carcinoma, Renal Cell in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| al-Sarraf, M; Ensley, JF; Kish, JA | 1 |
| Armand, JP; Cappelaere, P; Chevallier, B; Chollet, P; Hayat, M; Hurteloup, P; Roche, H; Van Glabbece, M | 1 |
2 other study(ies) available for esorubicin and Carcinoma, Renal Cell
| Article | Year |
|---|---|
Phase II evaluation of 4'deoxydoxorubicin in advanced renal cell carcinoma.
Topics: Antibiotics, Antineoplastic; Carcinoma, Renal Cell; Doxorubicin; Drug Evaluation; Humans; Kidney Neoplasms; Middle Aged; Remission Induction | 1990 |
Phase II trial of esorubicin in advanced renal carcinoma. Clinical Screening Group of the EROTC.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Carcinoma, Renal Cell; Doxorubicin; Drug Evaluation; Female; Humans; Kidney Neoplasms; Male; Middle Aged | 1989 |